AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Kala Pharmaceuticals Inc. (KALA)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

8.20

-0.17 (-1.97%)

At close: Jan 28, 2025, 1:39 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13
Revenue	n/a	3.89M	11.24M	6.36M	6.07M	n/a	n/a	n/a	45.00K	455.00K	50.00K
Cost of Revenue	303.00K	2.56M	4.10M	3.17M	2.01M	955.00K	643.00K	297.00K	n/a	455.00K	50.00K
Gross Profit	-303.00K	1.33M	7.14M	3.19M	4.07M	-955.00K	-643.00K	-297.00K	45.00K	n/a	n/a
Operating Income	-39.15M	-81.36M	-109.43M	-96.23M	-88.22M	-64.72M	-39.88M	-32.67M	-15.95M	-17.84M	-11.13M
Interest Income	2.71M	664.00K	104.00K	493.00K	2.36M	1.69M	527.00K	147.00K	n/a	n/a	n/a
Pretax Income	-42.20M	-44.82M	-142.60M	-104.33M	-94.35M	-66.74M	-42.21M	-33.17M	-16.68M	-19.36M	-10.65M
Net Income	-42.20M	-223.00K	-152.30M	-112.00M	-101.98M	-66.74M	-42.21M	-33.17M	-16.68M	-19.36M	-10.65M
Selling & General & Admin	20.26M	65.03M	105.06M	81.07M	65.02M	35.43M	10.87M	7.64M	4.61M	4.14M	3.25M
Research & Development	18.59M	17.65M	11.52M	18.35M	27.27M	29.29M	29.01M	25.03M	11.38M	13.86M	7.73M
Other Expenses	n/a	-926.00K	1.31M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	38.85M	82.69M	116.58M	99.42M	92.29M	64.72M	39.88M	32.67M	15.99M	18.00M	10.98M
Interest Expense	5.81M	7.27M	8.38M	8.59M	8.48M	3.31M	1.02M	767.00K	604.00K	1.61M	191.00K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	39.15M	85.25M	120.67M	102.59M	94.30M	64.72M	39.88M	32.67M	15.99M	18.30M	11.18M
Income Tax	n/a	-44.60M	9.69M	7.68M	7.64M	1.30M	732.00K	767.00K	604.00K	n/a	n/a
Shares Outstanding (Basic)	2.43M	1.52M	1.30M	1.05M	684.20K	535.08K	138.06K	345.67K	345.67K	483.67K	483.67K
Shares Outstanding (Diluted)	2.43M	1.52M	1.30M	1.05M	684.20K	535.08K	138.06K	345.67K	345.67K	483.67K	483.67K
EPS (Basic)	-17.35	-0.15	-116.79	-106.92	-149.06	-124.73	-305.74	-95.95	-48.26	-40.03	-22.03
EPS (Diluted)	-17.35	-0.15	-116.79	-106.92	-149.06	-124.73	-305.74	-95.95	-48.26	-40.03	-22.03
EBITDA	-36.08M	-36.70M	-131.96M	-92.90M	-83.25M	-62.47M	-40.55M	-32.10M	-15.75M	-17.45M	-10.26M
Depreciation & Amortization	303.00K	860.00K	2.27M	2.84M	2.62M	955.00K	643.00K	297.00K	330.00K	298.00K	201.00K